V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 190005639 | 190001093 | null | null | null | null | 2020-05-04 | Cisplatin + Gemcitabine (D 1 & 8) | null | null | CISPLATIN + GEMCITABINE | 101513694 |
| 190005650 | 190001097 | null | null | null | null | 2016-05-21 | Carboplatin + Etoposide iv&po | null | null | CARBOPLATIN + ETOPOSIDE | 101070857 |
| 190005663 | 190001101 | 0 | 32.3 | Curative (C) | 2017-01-02 | 2017-01-02 | Cisplatin 7 day | null | Y | CISPLATIN | 101417730 |
| 190005666 | 190001102 | null | null | null | null | 2018-05-01 | LANREOTIDE | null | null | CAPECITABINE + CARBOPLATIN | 101307813 |
| 190005676 | 190001106 | 1.73 | 69 | Curative (C) | 2019-09-12 | 2019-10-19 | VDC | 02 | Y | LANREOTIDE | 101632912 |
| 190005678 | 190001107 | 1.77 | 60 | null | 2018-02-27 | 2018-03-07 | Dox + HD Mtx (post PAM) | 02 | null | DOCETAXEL | 101317697 |
| 190005680 | 190001109 | 0 | 0 | Palliative (P) | 2016-05-22 | 2016-05-25 | Trial Unspecified | 02 | N | CISPLATIN + ETOPOSIDE | 100684185 |
| 190005685 | 190001110 | null | null | null | null | 2018-04-20 | IMATINIB | null | null | CABOZANTINIB | 101549240 |
| 190005686 | 190001111 | 0 | 0 | Adjuvant (A) | 2017-10-23 | 2017-10-29 | Cisplatin + Radiotherapy | 02 | N | CISPLATIN | 100111402 |
| 190005692 | 190001115 | null | null | null | null | 2019-06-08 | Cisplatin+Gemcitabine (gallbladder) | null | null | CISPLATIN + GEMCITABINE | 100727707 |
| 190005693 | 190001116 | 1.76 | 76 | 03 | 2018-04-13 | 2018-04-16 | ECX | 02 | N | CARBOPLATIN | 100375586 |
| 190005697 | 190001119 | null | null | null | null | 2018-12-09 | Carboplatin + Etoposide iv&po | null | null | CARBOPLATIN + ETOPOSIDE | 101272669 |
| 190005703 | 190001124 | 0 | 74.1 | Palliative (P) | 2016-11-12 | 2016-12-01 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | null | CISPLATIN + GEMCITABINE | 100145047 |
| 190005714 | 190001127 | null | null | null | null | 2020-10-01 | Cisplatin | null | null | CISPLATIN | 101333717 |
| 190005716 | 190001128 | 1.69 | 49.6 | Palliative (P) | 2016-02-09 | 2016-02-09 | EW EuroEwing 2012 Arm A VIDE | 02 | N | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 100612485 |
| 190005726 | 190001132 | null | null | null | null | 2017-01-06 | CISPLATIN + RT | null | null | CISPLATIN | 101247647 |
| 190005732 | 190001136 | 1.61 | 75.8 | Neo-adjuvant (N) | 2016-03-14 | 2016-03-24 | OST Euramos 1 Closed Trial - AP | 02 | N | OST AP | 100371493 |
| 190005744 | 190001140 | null | null | null | null | 2018-08-24 | OCTREOTIDE | null | null | CARBOPLATIN | 100508418 |
| 190005756 | 190001144 | 1.5 | 76.5 | Palliative (P) | 2016-11-20 | 2016-12-15 | Dox + HD Mtx (post PAM) | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101170811 |
| 190005761 | 190001147 | null | null | null | null | 2022-03-16 | Carboplatin + Etoposide iv&po | null | null | CARBOPLATIN + ETOPOSIDE | 100805211 |
| 190005765 | 190001149 | null | null | null | null | 2017-11-22 | Cisplatin + Radiotherapy | null | null | CISPLATIN | 100410514 |
| 190005769 | 190001150 | 1.89 | 83.4 | Palliative (P) | 2017-06-08 | 2017-07-16 | Cisplatin 7 day | 02 | N | CISPLATIN | 101500414 |
| 190005777 | 190001154 | null | null | null | null | 2017-09-15 | Carboplatin + Etoposide iv&po | null | null | CARBOPLATIN + ETOPOSIDE | 101204097 |
| 190005778 | 190001155 | 0 | 50.6 | Curative (C) | 2018-10-01 | 2018-10-01 | GC Int Guide Excranial GermCell JEB | 02 | N | CISPLATIN + DOXORUBICIN | 100169991 |
| 190005780 | 190001156 | 1.83 | 105 | Curative (C) | 2016-09-08 | 2016-09-08 | EOX | 02 | Y | CISPLATIN + DOCETAXEL + FLUOROURACIL | 100419348 |
| 190005781 | 190001157 | null | null | null | null | 2017-04-19 | CISPLATIN + GEMCITABINE | null | null | CISPLATIN + GEMCITABINE | 100116270 |
| 190005783 | 190001158 | null | null | null | null | 2018-05-24 | Cisplatin + Radiotherapy | null | null | CISPLATIN | 100245301 |
| 190005786 | 190001159 | null | null | null | null | 2019-10-30 | Cisplatin 100 + RT(H&N) 1 day | null | null | CISPLATIN | 101636347 |
| 190005789 | 190001161 | null | null | null | null | 2018-10-08 | Carboplatin AUC 6 - 10 | null | null | EW EUROEWING 2012 ARM B VDC | 100727066 |
| 190005790 | 190001162 | null | null | null | null | 2019-10-06 | Cisplatin + Gemcitabine (D 1 & 8) | null | null | CISPLATIN + GEMCITABINE | 100671034 |
| 190005791 | 190001163 | 1.71 | 69.6 | Palliative (P) | 2017-08-09 | 2017-08-09 | Cisplatin + Radiotherapy | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100651193 |
| 190005793 | 190001165 | 1.52 | 89.8 | Palliative (P) | 2018-02-18 | 2018-02-18 | Carboplatin + Paclitaxel (3 weekly) | 02 | 2 | CARBOPLATIN + PACLITAXEL | 101002034 |
| 190005795 | 190001166 | null | null | null | null | 2018-10-19 | Carboplatin + Etoposide IV 3 day | null | null | CARBOPLATIN + ETOPOSIDE | 101486266 |
| 190005796 | 190001167 | 1.78 | 58.6 | Palliative (P) | 2016-07-08 | 2016-07-20 | OST Euramos 1 Closed Trial - Ai | N | N | LUTETIUM-177 | 101215854 |
| 190005814 | 190001176 | 1.64 | 64.2 | Curative (C) | 2018-06-03 | 2018-06-10 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | CISPLATIN + GEMCITABINE | 100698463 |
| 190005817 | 190001177 | null | null | null | null | 2019-09-21 | OST Euramos 1 Closed Trial - Ai | null | null | CAPECITABINE + OXALIPLATIN | 101401828 |
| 190005823 | 190001180 | 1.61 | 51 | Curative (C) | 2018-03-28 | 2018-03-28 | Everolimus 10mg | 02 | N | GEMCITABINE | 100075908 |
| 190005825 | 190001181 | null | null | null | null | 2016-09-11 | Dox + HD Mtx (post PAM) | null | null | GEMCARBO | 101633110 |
| 190005828 | 190001182 | null | null | null | null | 2017-06-21 | OST Euramos 1 Closed Trial - AP | null | null | CAPECITABINE + TEMOZOLOMIDE | 100778528 |
| 190005838 | 190001184 | 1.65 | 57.4 | Curative (C) | 2016-08-24 | 2016-08-24 | EW EuroEwing 2012 Arm A VIDE | 01 | N | TEMOZOLOMIDE | 101797024 |
| 190005843 | 190001185 | 1.8 | 100 | Palliative (P) | 2016-12-31 | 2017-01-13 | Trial Unspecified | 02 | N | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 101701968 |
| 190005854 | 190001192 | 1.77 | 101 | Palliative (P) | 2016-08-17 | 2016-08-19 | Dox + HD Mtx (post PAM) | 01 | N | PEMBROLIZUMAB | 101305200 |
| 190005856 | 190001194 | 0 | 48 | Palliative (P) | 2020-12-30 | 2021-01-07 | OST Euramos 1 Closed Trial - Ai | 02 | N | BEP | 101128844 |
| 190005861 | 190001195 | 1.64 | 60.7 | Curative (C) | 2017-10-19 | 2017-10-19 | Carboplatin + Paclitaxel (weekly) | N | Y | CARBOPLATIN + PACLITAXEL | 100044803 |
| 190005863 | 190001197 | 1.61 | 72 | null | 2019-07-22 | 2019-07-27 | Carboplatin AUC 6 - 10 | 02 | Y | BLEOMYCIN + CISPLATIN + ETOPOSIDE | 101480889 |
| 190005867 | 190001199 | null | null | null | null | 2015-08-30 | Dox + HD Mtx (post PAM) | null | null | OST AP | 101170926 |
| 190005868 | 190001200 | 1.69 | 28.4 | Curative (C) | 2018-02-17 | 2018-03-10 | Trial Unspecified | 02 | N | CARBOPLATIN + CETUXIMAB + FLUOROURACIL | 100221616 |
| 190005869 | 190001201 | 1.78 | 76.3 | Curative (C) | 2016-05-11 | 2016-05-12 | Carboplatin + Docetaxel | 01 | N | OXALIPLATIN + MDG | 101194783 |
| 190005870 | 190001202 | null | null | null | null | 2017-05-22 | EW EuroEwing 2012 Arm A VIDE | null | null | CVD | 100307786 |
| 190005879 | 190001206 | 1.68 | 83 | Neo-adjuvant (N) | 2019-02-17 | 2019-02-21 | CISPLATIN + GEMCITABINE | null | null | CISPLATIN + GEMCITABINE | 100038396 |